Overview: Cyclospora TestIntroduction: The Cyclospora Test detects Cyclospora, a parasite causing diarrhea and fatigue, helping diagnose gastrointestinal infections and guide treatment. Affecting 1 in 10,000 travelers annually, this infection poses diagnostic challenges due to waterborne transmission. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses microscopy/PCR for high accuracy, supporting parasitology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in infectious disease management.
Other Names: Cyclospora Detection Test, Cyclosporiasis Assay.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic reliability.
Historical Milestone: Parasite testing began in the 1990s with research by Ortega, who identified Cyclospora. PCR advancements in the 2000s by Roche improved detection, surpassing earlier microscopy methods.
Purpose: Detects Cyclospora to diagnose gastrointestinal infections, guides antiparasitic therapy, and evaluates patients with diarrhea, aiming to resolve infection.
Test Parameters: Cyclospora presence
Pretest Condition: Fresh stool sample required. Collect sample. Report history of gastrointestinal symptoms.
Specimen: Stool (sterile container, 5-10 gm); Stool in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document diarrhea or fatigue. Include current medications or travel history.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., dehydration), and sample collection risks.
Procedural Considerations: Uses microscopy/PCR to detect Cyclospora, requiring labs with microscopes or thermal cyclers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample contamination or delay can affect results. Antiparasitics may reduce detection, requiring correlation.
Clinical Significance: Positive result confirms infection, guiding therapy. Early treatment might prevent dehydration, while untreated cases lead to worsening. Negative results may require other parasite tests.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Stool culture, ova and parasite exam, or travel history to confirm diagnosis.
Test Limitations: Specific to Cyclospora; correlation with symptoms needed. False negatives possible with prior treatment.
References: CDC Guidelines, 2023; Clinical Infectious Diseases, Ortega YR, 2022.
